HR 5377 United States House · 117th Congress

Cancer Patient Equity Act of 2021

Summary

Cancer Patient Equity Act of 2021 This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Sep 2021

Committee Review

Floor Vote

President

Introduced Sep 27, 2021 Last action Sep 28, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Sep 28, 2021

Committee

Referred to the Subcommittee on Health.

lower

Sep 27, 2021

Committee

Referred to the Subcommittee on Health.

lower

Sep 27, 2021

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Sep 27, 2021

Introduced

Introduced in House

lower

1 primary · 19 co-sponsors